Cargando…

Medicines as a service : a new commercial model for big pharma in the postblockbuster world /

The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Mattke, Soeren
Autor Corporativo: RAND Health
Otros Autores: Klautzer, Lisa, Mengistu, Tewodaj
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Santa Monica, CA : RAND Health, [2012]
Colección:Occasional paper (Rand Corporation)
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 JSTOR_ocn893183697
003 OCoLC
005 20231005004200.0
006 m o d
007 cr cn|||||||||
008 140829s2012 cau ob 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c NLM  |d EBLCP  |d MHW  |d E7B  |d STF  |d KLG  |d S4S  |d JSTOR  |d OCLCF  |d DEBSZ  |d YDXCP  |d AU@  |d NKT  |d CUS  |d ZCU  |d MERUC  |d OCLCQ  |d COCUF  |d LND  |d OCLCO  |d VFL  |d OCLCA  |d U3W  |d OCLCA  |d LOA  |d ICG  |d WRM  |d OCLCQ  |d NRAMU  |d OCLCA  |d VT2  |d EZ9  |d OCLCQ  |d TKN  |d DKC  |d OCLCQ  |d OCLCO  |d OCL  |d PIFAG  |d N$T  |d AGLDB  |d COO  |d D6H  |d VNS  |d VTS  |d AJS  |d OCLCQ  |d OCLCO 
016 7 |a 101640300  |2 DNLM 
019 |a 804665552  |a 818105683  |a 842699759  |a 903663785  |a 907209128 
020 |a 9780833076465 
020 |a 0833076469 
020 |a 9780833076458  |q (electronic bk.) 
020 |a 0833076450  |q (electronic bk.) 
029 0 |a NLM  |b 101640300 
029 1 |a AU@  |b 000050968007 
029 1 |a AU@  |b 000052909815 
029 1 |a AU@  |b 000053024048 
029 1 |a CHNEW  |b 000619499 
029 1 |a DEBBG  |b BV044167510 
029 1 |a DEBSZ  |b 397356706 
029 1 |a GBVCP  |b 1008662488 
029 1 |a NZ1  |b 14692729 
029 1 |a DEBSZ  |b 493158170 
035 |a (OCoLC)893183697  |z (OCoLC)804665552  |z (OCoLC)818105683  |z (OCoLC)842699759  |z (OCoLC)903663785  |z (OCoLC)907209128 
037 |b 00022221 
037 |a 22573/ctt99zkn  |b JSTOR 
042 |a nlmcopyc 
050 4 |a HV5840  |b .M38 2012 
060 0 0 |a WT 500 
072 7 |a MED071000  |2 bisacsh 
082 0 4 |a 362.29/90941 
049 |a UAMI 
100 1 |a Mattke, Soeren. 
245 1 0 |a Medicines as a service :  |b a new commercial model for big pharma in the postblockbuster world /  |c Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. 
260 |a Santa Monica, CA :  |b RAND Health,  |c [2012] 
300 |a 1 online resource (1 PDF file (11 pages)) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Occasional paper 
500 |a Title from PDF caption. 
504 |a Includes bibliographical references. 
520 3 |a The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value. 
588 0 |a Version viewed Sept. 9, 2014. 
505 0 |a Medicines as a Service. 
590 |a JSTOR  |b Books at JSTOR All Purchased 
590 |a JSTOR  |b Books at JSTOR Open Access 
650 0 |a Pharmaceutical services. 
650 0 |a Pharmaceutical industry. 
650 0 |a Mathematical models. 
650 1 2 |a Chronic Disease  |x drug therapy 
650 2 2 |a Drug Industry  |x economics 
650 2 2 |a Medication Adherence 
650 2 2 |a Developing Countries 
650 2 2 |a Models, Theoretical 
650 2 |a Pharmaceutical Services 
650 2 |a Drug Industry 
650 6 |a Services pharmaceutiques. 
650 6 |a Industrie pharmaceutique. 
650 6 |a Modèles mathématiques. 
650 7 |a mathematical models.  |2 aat 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Mathematical models  |2 fast 
650 7 |a Pharmaceutical industry  |2 fast 
650 7 |a Pharmaceutical services  |2 fast 
700 1 |a Klautzer, Lisa. 
700 1 |a Mengistu, Tewodaj. 
710 2 |a RAND Health. 
776 0 8 |i Print version:  |a Mattke, Soeren.  |t Medicines as a Service : A New Commercial Model for Big Pharma in the Postblockbuster World.  |d Santa Monica : RAND Corporation, ©2012 
830 0 |a Occasional paper (Rand Corporation) 
856 4 0 |u https://jstor.uam.elogim.com/stable/10.7249/op381hlth  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL981579 
938 |a ebrary  |b EBRY  |n ebr10583965 
938 |a YBP Library Services  |b YANK  |n 9454829 
938 |a EBSCOhost  |b EBSC  |n 471726 
938 |a YBP Library Services  |b YANK  |n 10887288 
994 |a 92  |b IZTAP